OREM, UT, June 17, 2014 /24-7PressRelease/
-- Despite almost 50% of organizations citing clinician adoption as the number-one challenge to front-end speech (FES) deployment, 9 out of 10 of the interviewed hospitals still plan to expand its use. This and other key findings are revealed in the latest KLAS report, entitled Front-End Speech 2014: Functionality Doesn't Trump Physician Resistance
Facilities interviewed saw a higher impact in nearly every category measured in the study, including reduced transcription costs, reduced documentation time and more complete patient-narratives.
"Physicians are resistant to changes in their workflow," says report author Boyd Stewart. "While hospital leadership sees the value of FES, many end users are frustrated that they are now being asked to do the work of transcriptionists."
As part of this study, KLAS interviewed organizations across the country about their front-end speech software. The vendors reviewed in the study are Dolbey, M*Modal and Nuance.
For more-detailed information on each vendor's performance, visit KLAS online at www.KLASresearch.com/reports
to see the KLAS report Front-End Speech 2014: Functionality Doesn't Trump Physician Resistance
. The report is available to healthcare providers and vendors. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey about one of their current suppliers.About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch